Drug Testing and Product Training
Transcription
Drug Testing and Product Training
Drug Testing and Product Training TABLE OF CONTENTS A. Drugs of Abuse and Testing 1. Trends in Drug Use 2. Who’s Using Drug Testing? 3. Types of Testing: Screening and Confirmation 4. Types of Testing (Table) 5. Screenings Offered by DrugCheck® 6. Detection Times and Cutoff Levels 7. False Positives B. DrugCheck® Urine Tests 1. 2. 3. 4. DrugCheck® Urine Tests Reading a Test Result Adulterants K2/Spice 5. Fentanyl TABLE OF CONTENTS D. DrugCheck® Saliva Tests 1. 2. 3. 4. 5. Oral Fluid Drug Testing DrugCheck® SalivaScan™ Sponge Saturation Indicator Features and Benefits DrugCheck® SalivaScan™ MarketLeading Drug Cutoffs 6. DrugCheck® SalivaScan™ Testing Procedure E. DrugCheck® Products 1. VeriCheck™ F. AlcoCheck™ Products 1. 2. 3. 4. 5. 6. 7. Urine Alcohol Testing AlcoCheck™ Saliva Alcohol Screen Alco-Screen 02 AlcoCheck™ FC90 AlcoCheck™ FC200 AlcoCheck™ Breath Alcohol Screen AlcoCheck™ Accessories DRUGS OF ABUSE AND TESTING DRUGS OF ABUSE AND TESTING Trends in Drug Use About 22.6 million Americans or 8.9% of the population are current users of illicit drugs, meaning they use at least once per month: • 13.3 million employed Americans • 4.2 million dependent on illicit drugs • 15 million dependent on alcohol Total economic cost = $193 billion http://www.oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm#7.1 http://www.justice.gov/archive/ndic/pubs44/44731/44731p.pdf DRUGS OF ABUSE AND TESTING Trends in Drug Use Treatment admissions for opiates other than heroin rose from 19,870 in 1998 to 111,251 in 2008, over a 450-percent increase . 80% of the world's supply of opioid analgesics are consumed in the U.S, but we only have 5% of the world's population California - Oxy abusers turning to heroin in San Diego County Naloxone (Narcan) Nasal Spray is a response to opioid overdose epidemic to avoid needle –sticks and contracting diseases like Hepatitis and HIV DRUGS OF ABUSE AND TESTING Who’s using drug testing? • • • • • • • • • • • • Workplaces with safety-sensitive environments DOT vs. non-DOT Manufacturing Construction Energy (oil, gas, utilities) Retail Gaming Security Government Healthcare Schools Corrections: Probation/Parole Corporations • Wal-Mart • McDonalds • GM • UPS • Ford • Sears • IBM • GE • Kroger • JC Penny/Eck. 1.2 million 364,000 363,000 359,000 346,000 323,000 320,000 313,000 312,000 265,000 DRUGS OF ABUSE AND TESTING Department of Transportation Industry Safety – Sensitive Positions Commercial Motor Carriers (FHWA) Anyone holding a Commercial Driver’s License Aviation (FAA) Flight crew, attendants, instructors, air traffic controllers at facilities not operated by the FAA or under contract to the U.S. military; aircraft dispatchers; aircraft maintenance or preventative maintenance personnel; ground security coordinators and aviation screeners Maritime (USCG) Crewmembers operating a commercial vessel Mass Transit (FTA) Vehicle operators, controllers, mechanics and armed security personnel Pipeline (RSPA) Operations, maintenance & emerg. response personnel Railroad Hours of Service Act employees: engine, train, & signal services, dispatchers and operations DRUGS OF ABUSE AND TESTING Types of Testing: Screening and Confirmation • A screening test is an initial test for drugs. It can be an onsite test like DrugCheck® or a test that is done on a chemistry analyzer. It is usually non-quantitative. • A confirmation test is often more sensitive and more specific (selective) that a screening test and is usually quantitative. • An example of a confirmation assay is gas chromatography/masspectrometry (GC/MS or LC/MS) • Positive screening tests should be confirmed by GC/MS or LC/MS. DRUGS OF ABUSE AND TESTING Types of Testing Type Pros Cons Window of Detection Urine • Most reliable results • Least expensive • Most flexibility in testing different drugs, alcohol & nicotine • Most likely of all methods to withstand legal challenge • Specimen can be adulterated, substituted or diluted • Limited window of detection • Typically 1 to 5 days, THC may be longer Hair • • • • • • Most expensive • Test usually limited to basic 5 drugs • Cannot detect alcohol use • Will no detect recent drug use. (1 to 7 days prior to test) • Depends on length of hair. Hair growth = half an inch per month • Specimen shows 3 month history • Less efficient in detecting THC • Sample dries out, multiple sample testing not practical • More expensive than urine testing • Drugs and metabolites do not remain in oral fluids as long as in urine • Approx. 10 to 24 hours Oral Fluids Longer window of detection Greater specimen stability Can measure chronic use Easy to ship and store More difficult to adulterate than urine • Sample obtained under direct observation • Minimal risk of tampering and collected in any environment • Can detect alcohol use • Reflects recent drug use DRUGS OF ABUSE AND TESTING Detection Times and Cutoff Levels SAMHSA (Substance Abuse and Mental Health Services Administration) Cutoffs The “Cutoff Level” is the concentration level established as a breakpoint or threshold for labeling a result Positive or Negative (e.g. 50 ng/mL THC or 300 ng/mL Cocaine) The concentration of a drug is expressed in nanograms (ng) per milliliters (mL), or ng/mL. One nanogram is equal to one billionth of a gram and 1 mL is equal to about 1/30 of a fluid ounce. DRUGS OF ABUSE AND TESTING Screenings Offered by DrugCheck® Test Strip Drug Urine Saliva Alcohol 0.04% Drug Urine Saliva 0.02% Ketamine 1000 50 300, 500 50 Marijuana 25, 50, 300 12, 50(parent) 300 50 MDMA/Ecstasy 500 - Benzodiazepine 200, 300 10 Methadone 300 30 Buprenorphine 10 5 Methamphetamine 300, 500, 1000 50 Cocaine 150, 300 20 Opiates 300, 2000 40 Cotinine 200 50 Oxycodone 100 40 EDDP/Methadone 100 20 Phencyclidine 25 10 Fentanyl 200 - Propoxyphene 300 50 10, 50 - Tramadol 100 - 25 - Tricyclic Antidepressants 1000 - Amphetamine Barbiturate GHB K2/Spice Test Strip All cutoffs ng/mL, except alcohol DRUGS OF ABUSE AND TESTING Detection Times and Cutoff Levels Drug Type Detection Time Cutoff Levels (ng/mL) Screen GC/MS Up to 24 hours - - 2 to 4 days 1000 500 Barbiturates 1 to 2 days Phenobarb 2 to 3 weeks 300 200 Benzodiazepines Normal use: 1 to 3 days Chronic use: weeks 300 200 Buprenorphine 2 to 4 days 10 10 Cocaine 2 to 4 days 300 150 Cotinine 2-4 days Up to 30 days or longer with Chronic use - - EDDP/Methadone 1 to 4 days 300 200 Fentanyl 1 to 3 days - - 1 day - - Normal use: 1 to 3 days Chronic use: weeks - - Alcohol Amphetamine GHB K2/Spice All cutoffs ng/mL, except alcohol DRUGS OF ABUSE AND TESTING Detection Times and Cutoff Levels Drug Type Detection Time Cutoff Levels (ng/mL) Screen GC/MS Ketamine Normal use: Up to 14 days Chronic use: Up to 30 days - - Marijuana Up to 10 days (with heavy use up to 30 days) 50 15 MDMA/Ecstasy 1 to 3 days 500 Parent drug Methadone 1 to 3 days 300 200 Methamphetamine 2 to 4 days 1000 500 Opiates 2000 or 300 ng/mL 1 to 2 days 2000 2000 Oxycodone 1 to 3 days 100 100 Phencyclidine Normal use: Up to 14 days Chronic use: Up to 30 days - - Propoxyphene 3 to 4 days 300 300 Tramadol 1 to 3 days - - Therapeutic dose: 3 days Chronic use: Up to 4 weeks - - Tricyclic Antidepressants All cutoffs ng/mL, except alcohol DRUGS OF ABUSE AND TESTING False Positives POPPY SEED BAGELS Avg. bagel has 5 grams of poppy seeds yielding about 600 to 700 ng/mL of morphine concentration 24 hours after ingestion. New cutoff level is 2,000 not 300. PROTON PUMP INHIBITORS, like protonix, Prilosec, Prevacid, and Nexium, that treat GERD, may cause false positives with THC. SUSTIVA, ATRIPLA (efavirenz) HIV antiviral causes false positive with THC. Over $282 million sold in 2003. New DrugCheck® THC does not cross-react. EFFEXOR may cause a false positive with PCP. Over $2 billion sold in 2003. ZOLOFT (sertraline) may cause a false positive for BZD. Over $2.5 billion sold in 2003. PHENTERMINE (Pro-Fast, Teramine) may cause a positive result with Amphetamine. DAYPRO (Oxaprozin) a popular medication for arthritis may cause a false positive for Benzodiazepines. ADDERALL a treatment for ADHD, may cause a positive for amphetamines. DRUGS OF ABUSE AND TESTING False Positives Stribild medication for HIV-1 (cobicistat / elvitegravir / emtricitabine / tenofovir) false positive for THC and PCP Naltrexone (Vivtrol) used in the management of alcohol dependence and opioid dependence False positive for oxycodone. Naloxone (Narcan) is an opioid antagonist. Naloxone is used to counter the effects of opioid overdose. Also Naloxone is added to Suboxone in an effort to dissuade patients from injecting the tablets. False positive for oxycodone Flexeril (cyclobenzaprine) muscle relaxant, may cause false positive with methadone DRUGS OF ABUSE AND TESTING False Positives Tramadol (Ultram) may give a Zolpidem (Ambien) can give false positive for burenorphine especially if the dose is increased. a false positive for benzodiazepine. Tramadol works in a similar way as many antidepressant medications in that it increases the levels of serotonin in your brain. Many clients on suboxone will take tramadol to get an increase in the euphoric effect. Egyptians are using the pill as a recreational drug and also, reportedly, as an aphrodisiac. But most commonly, it serves as a cheap energy boost about $3 for a sheet of ten pills. Zolpidem Benzodiazepine DRUGS OF ABUSE AND TESTING Cross Reactivity Drug Panel Cross React. Pharm. Name Brand Name Drug Use Oxycodone In product insert Oxycodone OxyContin/Percolone/ Roxicodone Moderate to severe pain In product insert Hydrocodone Vicodin Analgesic with acetaminophen In product insert Hydromorphine Dilaudid Pain Management In product insert Oxymorphone Numorphan Treatment for moderate to severe pain In product insert Codeine Codeine Pain Management / cough medicine Potential Dextromethorphan Dextromethorphan Treat cough Potential Diphenhydramine Benadryl Allergies Potential Thioridazine Mellaril Tranquilizer for psychotic disorders Potential Veniafaxine Effexor Antidepressant In product insert Phencyclidine PCP Phencyclidine (PCP) DRUGS OF ABUSE AND TESTING Cross Reactivity DrugCheck® Urine Tests K2/Spice Synthetic Cannabinoids Timeline • • • • • • First appearance on the Internet 2004 Europe was original target market By 2008 widespread in Europe 2008 introduced into US Widespread in US by late 2008 - 2009 Late 2008 University Hospital Freiburg, Germany first analysis of incense • First email Spring 2009 • Laboratory testing available late 2010 • March 1, 2011 classified as Schedule I substance DrugCheck® Urine Tests K2/Spice Street names Black Mamba, Bombay Blue, Cloud Nine, Fake Weed, Genie, Spice, Zohai Looks like K2 is typically sold in small, silvery plastic bags of dried leaves and marketed as incense that can be smoked. It is said to resemble potpourri. Methods of abuse K2 products are usually smoked in joints or pipes, but some users make it into a tea. Affect on mind Psychological effects are similar to those of marijuana and include paranoia, panic attacks, and giddiness. False Positives – Lamotrigine (Lacmictal) K2 Symptoms/Side-Effects may include Increased respiration and elevated blood pressure (reported up to 200/100-medically dangerous) Elevated heart rate (reported up to rate of 150medically dangerous) Increased level of anxiety/agitation leading to panic attacks (possible suicide attempts) Synthetic Cannabinoids: CBs Synthetic Cannabinoids: CBs K2 Spice Dip Compounds Detected JWH-018 N-propanoic acid JWH-018 5-pentanoic acid metabolite JWH-018 N-4-hydroxypentyl JWH-018 N-5-hydroxypentyl JWH-019 6-hydroxyhexyl JWH-019 5-hydroxyhexyl JWH-073 4-butanoic acid metabolite JWH-073 N-2-hydroxybutyl JWH-073 N-4-hydroxybutylame JWH-122 N-4-hydroxypentyl JWH-122 N-5-hydroxypentyl JWH-200 6-hydroxyindole JWH-210 N-(5-carboxypentyl) metabolite C26H25NO3 JWH-398 N-pentanoic acid metabolite MAM2201 N-pentanoic acid metabolite RCS-4 N-(5-carboxypentyl) metabolite C21H21NO4 DrugCheck® Urine Tests K2/Spice JWH-018 (mg/g) JWH-073 (mg/g) CP47,497 (n=8) (mg/g) JWH-250 (mg/g) K2 Blonde 12 13 - - K2 Standard 9 9 - - K2 Citron 10 10 - - K2* (Unknown) - - 6 - K2 Summit 11 9 - - K2 Blue 15 - - - K2 Pink 11 - - - K2 Latte 16 0.28 - 14 K2 Mint 19 0.30 - - K2 Silver 8 - - 16 Spike Gold 20 11 - - Spike Maxx 17 - - 19 Spike Diamond 17 0.07 - - Spike Silver 9 16 - - Space 10 - - - Herbal blends* 2.0 – 35.9 - 1.1 – 16.9 - Chemicals - Prevalance 2010 July – December 2010 Chemicals – Prevalence 2012 Jan–Mar 2012 Fentanyl Killer Heroin’ Causing Fatal Overdoses in East As the number of people who use, and fatally overdose on, heroin has skyrocketed in recent years, authorities are seeing the return of an alarming development: heroin that, often unbeknownst to the user, is spiked with fentanyl. Md. Has 37 Deaths From Heroin, Fentanyl Overdoses BALTIMORE — Maryland’s medical examiner says there have been at least 37 deaths since September in the state from a batch of heroin that is tainted with fentanyl. Fentanyl Fentanyl is a powerful synthetic opiate analgesic . It is typically used to treat patients with severe pain, or to manage pain after surgery. It is also sometimes used to treat people with chronic pain who are physically tolerant to opiates. It is a schedule II prescription drug Names In its prescription form, fentanyl is known as Actiq, Duragesic, and Sublimaze. Street names for the drug include Apache, China girl, China white, dance fever, friend, goodfella, jackpot, murder 8, TNT, as well as Tango and Cash. Fentanyl is 100 times more potent than morphine. 100 micrograms of Fentanyl approximately equivalent to 10 mg of morphine. 1mg = 1000 micrograms (ug) Some heroin dealers mix fentanyl powder with heroin in order to increase potency or compensate for low-quality heroin. The mixture of fentanyl and heroin is known as "magic" or "the bomb", among other names, on the street Krokodil DrugCheck® Urine Tests DrugCheck® Urine Tests Test Principle DrugCheck® Urine Tests Reading a Test Result • Presumptive Positive: One colored line in control (C) zone; no colored line in test (T) zone • Negative: Colored lines are visible in both control (C) and test (T) zones, indicates concentration of drug is below detection limit of test or not present • Note: Test lines (T) may have varying intensity, either weaker or stronger in color than that of the control line (C). However, any indication of a line in the test region should be interpreted as a negative result. DrugCheck® Urine Tests Adulterants DrugCheck® Urine Tests Adulterants The Wedge (La Cuña) DrugCheck® Urine Tests Adulterants Adulterant Drug Test Affected Adulteration Strip Affected THC, OPI, AMP pH, SG, Oxid OPI, AMP pH, SG AMP SG THC, COC, OPI, PCP, AMP SG, Oxid Stealth THC, COC, PCP Oxid Instant Clean THC, COC, PCP Oxid THC, COC, OPI, PCP SG Chlorine Bleach Liquid Drain Cleaner Vinegar Pyridinium Cl Cr (PCC) UR’n Kleen DrugCheck® Urine Tests DrugCheck® NxScan Procedure: Specimen Collection 9. Check temperature (normal range from 90° to 100°F or 32°to 38°C) and observe specimen for foreign material and/or discoloration If the temperature is not within the normal range, the specimen is considered invalid and must be retested. Peel the privacy label. Read results at 5 minutes. 10. Pull privacy label and read drug test strip results at 5 minutes. Read adulterant strips at 1 minute and alcohol strips at 2 minutes. 11. Secure container by tightening lid as far as it will turn, apply security seal, and have donor and test administrator both sign and date seal, as well as initial and date the NxScan label. DrugCheck® Urine Tests Adulterants • • • Adulteration results are obtained by comparison of the colored pads on reacted strips to color blocks on the Adulterant Color Chart. Adulterated urine will show result colors similar to those in the “Abnormal” columns of the color chart, either high or low. Unadulterated samples will show strip colors similar to those in the “Normal” column. Adulterants available: – – – – – – • Creatinine (CR) Glutaraldehyde (GL) Nitrite (NI) Oxidants/Bleach (OX) pH Specific Gravity (SG) EDI offers 3 adulterants per strip – CR-GL-NI – OX-pH-SG DrugCheck® Urine Tests DrugCheck® NxStep • Configurations of up to 15 drugs and/or adulterants and alcohol • FDA cleared for 17 drugs • Combined collection cup and testing device delivers instant results, convenience, accuracy • Detects presence of drug metabolites in minutes, using SAMHSA cutoffs DrugCheck® Urine Tests DrugCheck® NxScan Procedure: Specimen Collection 1. Have available for use a Chain of Custody form (COC) or Test Results Record template. for and remove cleaners and other substances, secure toilet tank top or blue tank water. 2. Require the donor to present a photo identification.\ 6. Visually inspect foil package containing the cup to ensure that the package has not been compromised. Tear open the foil pouch and remove the test cup. 3. Ask donor to remove any unnecessary outer clothing and empty all pockets. NOTE: Urine Specimens can be transferred from a urine collection container into the DrugCheck® Test Cup, if necessary 4. Keep all backpacks and purses out on the restroom. Insure that all backpacks, wallets and purses are secured, preferably in a locked cabinet. If using a lockable cabinet of container, make sure that the donor is given the key. 5. Secure the collection site (restroom). Turn off water sources (sink faucets), ensure blue toilet water, inspect site 7. Issue the device to the individual to be tested. Instruct the donor not to flush the toilet or turn the water on and to open the door when they are done. 8. Have the individual urinate directly into the DrugCheck® Test Cup. Ensure that the specimen is above the minimum level (30 mL) line on the test label. DrugCheck® Urine Tests DrugCheck® NxScan Procedure: Specimen Collection 9. Check temperature (normal range from 90° to 100°F or 32°to 38°C) and observe specimen for foreign material and/or discoloration If the temperature is not within the normal range, the specimen is considered invalid and must be retested. Peel the privacy label. Read results at 5 minutes. 10. Pull privacy label and read drug test strip results at 5 minutes. Read adulterant strips at 1 minute and alcohol strips at 2 minutes. 11. Secure container by tightening lid as far as it will turn, apply security seal, and have donor and test administrator both sign and date seal, as well as initial and date the NxScan label. DrugCheck® Urine Tests DrugCheck® NxScan • Flat panel cup for copying or scanning for permanent record • Configurations of up to 14 drugs and/or adulterants and alcohol • FDA cleared for 17 drugs DrugCheck® Products VeriCheck • • • • • • Automated interpretation One-click activation Qualitative analysis of assays Results database – produce and print reports Read/interpret multiple tests with minimal user interaction Bar-coded template contains all information required to process device • Read lateral-flow tests with: – 1 to 14 strips – Color pads, such as adulterants: pH, NI, GL, CR, OX, SG • Affordable, accurate diagnostic test reading system for hospitals, point-of-care organizations, labs and more DrugCheck® Urine Tests Drugcheck Advantages What distinguishes DrugCheck NxStep and NxScan test cups from other on-site products is: – No handling or manipulation to activate testing – No tipping or tilting cup to activate test – No dipping reagent strips or test cards into specimen – No dripping specimen with pipettes – Compatible with VeriCheck Results Manager – U.S. made DrugCheck® Urine Tests DrugCheck® Dip Tests • Single- and multi-drug devices, as well as single test strips • Rapid, qualitative immunoassay - detect up to 14 drugs; FDA cleared for 17 drugs • Dip test strips in urine sample for 15 seconds; read results at 5 min • Flood-proof label • 18-month shelf life • No urine to pipette DrugCheck® Urine Tests DrugCheck® 9-Panel Pipette • Rapid, qualitative immunoassay for detection of up to nine drugs of abuse at SAMHSA cutoff levels – AMP/COC/OPI/THC/MET/BZO/BAR/PCP/MTD • Simply transfer urine via pipette (dropper) to wells of test device; read test results at 5 min • 18-month shelf life • No instrumentation • Made in U.S.A. DrugCheck® Saliva Tests DrugCheck® Saliva Tests SalivaScan™ Testing Procedure 1 Remove device from foil pouch Remove collection swab from plastic pouch DrugCheck® Saliva Tests Procedure: Specimen Collection 2 IMPORTANT: DONORS SHOULD NOT PLACE ANYTHING (INCLUDING FOOD, DRINK, GUM, OR TOBACCO PRODUCTS) IN THEIR MOUTH FOR AT LEAST 10 MINUTES PRIOR TO THE PROCEDURE. DO NOT BITE, SUCH, OR CHEW ON THE SPONGE. REFRAIN FROM TALKING WHILE COLLECTION SWAB IS IN THE MOUTH. DrugCheck® Saliva Tests Procedure: Specimen Collection 2 Sponge Saturation Indicator Donor may remove swab from mouth when color appears in the indicator window The purpose of Step 2 is to saturate the sponge with saliva. With collection swab, have donor sweep the inside of mouth (cheek, gums, tongue) several times, then hold swab in closed mouth until color on the saturation indicator strip appears in the indicator window of the collection swab. Donor must leave swab in mouth until instructed to remove it. Note: If at 7 minutes, color on saturation indicator has not appeared in indicator window, proceed with test. DrugCheck® Saliva Tests Procedure: Assay 3 Remove collection swab (B) from mouth and insert the sponge first into the screening device (A), pushing until the locking flange locks in place in the bottom of the device. NOTE: Once the collection swab locks in place, the device is airtight, tamper evident, and ready to dispose of or send to lab for confirmation (on presumptive positive result). DrugCheck® Saliva Tests Procedure: Assay 3 Ensure that specimen is contacting all test strips. If not, rotate the device side to side / front to back to disperse the specimen within the chamber. With specimen dispersed, set device upright on flat surface and keep upright while test is running. DrugCheck® Saliva Tests Procedure: Read Results 4 Read negative results as soon as two lines appear on any test strip, often within 2 minutes. Any indication of a line in the test region (T) should be considered a line, and therefore a negative result. Read presumptive positive results within 10 minutes. If the device includes alcohol, read the alcohol strip at 2 minutes. DrugCheck® Saliva Tests DrugCheck® SalivaScan™ • “SalivaScan is our single greatest accomplishment as a company thus far. This device is unequaled in the industry and will help define EDI as not just a manufacturer, but an innovator. With this device our Sales and Marketing team has the opportunity to take this company to a whole new level!” – Paul Johnson DrugCheck® Products VeriCheck • • • • • • Automated interpretation One-click activation Qualitative analysis of assays Results database – produce and print reports Read/interpret multiple tests with minimal user interaction Bar-coded template contains all information required to process device • Read lateral-flow tests with: – 1 to 14 strips – Color pads, such as adulterants: pH, NI, GL, CR, OX, SG • Affordable, accurate diagnostic test reading system for hospitals, point-of-care organizations, labs and more AlcoCheck™ Products Urine Alcohol Testing Alcohol is responsible in the world for 2.5 million deaths and results in disability in approximately 58.3 million people per year. AlcoCheck™ Products Urine Alcohol Testing Factors that Affect Alcohol Absorption • Time of consumption • Type of alcoholic beverage • Presence of food in stomach • Body weight • Rate of alcohol absorption AlcoCheck™ Products Urine Alcohol Testing Alcohol and the Law Try the drink wheel: http://www.intox.com/wheel/drinkwheel.asp AlcoCheck™ Products Urine Alcohol Testing Alcohol and the Law • 1939-1964: intoxicated = 0.15% BAC • 1965: intoxicated = 0.10% BAC • 2003: intoxicated = 0.08% BAC At least we don’t live in France, Germany, Ireland, or Japan (0.05%) or especially Sweden (0.02%)! AlcoCheck™ Products Urine Alcohol Testing • Peak urine alcohol levels are reached 45 to 60 minutes after alcohol ingestion • Alcohol may be detected in the urine for 1 to 2 hours longer than it is detected in the blood AlcoCheck™ Products Urine Alcohol Testing • Negative result shows no change from the original light yellow color on the test strip pad • Urine with alcohol at specific levels will be indicated on the test strip pad according to the color on color chart Part No. 40901 and 40901C AlcoCheck™ Products AlcoCheck Saliva Alcohol Screen • Rapid, semi-quantitative detection of alcohol in saliva • Place test strip in mouth for 10 sec; after 2 min compare reactive pad to color to color chart on pouch • Easy-to-read interpretation chart provided on package • Adulteration and dilution is not an issue • Indicates recent alcohol usage • Gender neutral Part No. 40900 AlcoCheck™ Products AlcoCheck Breath Alcohol Screen • Simple, convenient method to detect alcohol use and to estimate levels of intoxication • Pass/fail design detects alcohol at different threshold levels - .02, .04, .05, .08 • Procedure: Squeeze tube to crush the ampoule, then blow into end of tube for 12 sec • Yellow crystals remain unchanged if alcohol is not present at the test’s threshold. Alcohol in the breath that meets or exceeds the test’s threshold turns yellow crystals to a pale blue/green color within 2 min # 40902, # 40904, # 40905, # 40908 - Boxes of 25 AlcoCheck™ Products AlcoCheck FC90 • • • • • • • • • • Electrochemical European fuel cell sensor Display range: 0.000-0.200%BAC Audible sound alarm if above 0.05%BAC Low-battery indicator/Auto power-off Calibration interval: 12 months Blowing time: 6 sec Memory: 5 records Blowing flow detection 1-year warranty CE registered, DOT cleared AlcoCheck™ Products AlcoCheck FC200 • Results can be printed via USB cable connection to optional printer • Onboard memory • Advanced European fuel cell sensor • Low-battery indicator/Auto power-off • Advanced blow-flow detection • Available in EU format • 1 year warranty • Accuracy established at BAC of 0.008; backlit screen changes color when alcohol content of sample exceeds 0.08